We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product c... Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004). Show more
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today...
Net cash provided by operating and investing activities was $15.8 million in the second quarter and net cash used by operating and investing activities was $57.3 million for the first six months...
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today...
Prothena to receive $80 million from Bristol Myers Squibb for exclusive global license to PRX019, a potential treatment of neurodegenerative diseases with an undisclosed target Prothena will...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.45 | -2.0316027088 | 22.15 | 22.41 | 20.96 | 555174 | 21.70872084 | CS |
4 | -0.14 | -0.641025641026 | 21.84 | 22.83 | 20.12 | 318625 | 21.46839125 | CS |
12 | 1.28 | 6.26836434868 | 20.42 | 25.42 | 18.99 | 370199 | 21.80781178 | CS |
26 | -4.12 | -15.956622773 | 25.82 | 26.36 | 18.69 | 461506 | 21.8686207 | CS |
52 | -28.5 | -56.7729083665 | 50.2 | 55.89 | 18.69 | 631742 | 30.34295806 | CS |
156 | -56.3 | -72.1794871795 | 78 | 79.749 | 18.69 | 527803 | 42.00870826 | CS |
260 | 13.36 | 160.191846523 | 8.34 | 79.749 | 6.44 | 443355 | 36.96122703 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions